Lymphoma

Table of Contents

Table of Contents

  • Lymphoma -
  • Special Issue
  • Volume 2015
  • - Article ID 123548
  • - Research Article

Non-Hodgkin Lymphoma in Children with Primary Immunodeficiencies: Clinical Manifestations, Diagnosis, and Management, Belarusian Experience

Alina Fedorova | Svetlana Sharapova | ... | Olga Aleinikova
  • Lymphoma -
  • Special Issue
  • Volume 2014
  • - Article ID 597908
  • - Research Article

FoxP3-Positive T-Regulatory Cells in Lymph Nodes with Mycosis Fungoides and Sézary Syndrome

Rekha Bhat | Bhavna Khandpur | ... | J. Steve Hou
  • Lymphoma -
  • Special Issue
  • Volume 2014
  • - Article ID 160421
  • - Clinical Study

Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature

Uma Maheswari Krishnaswamy | Vinayak V. Maka | ... | Nalini Kilara
  • Lymphoma -
  • Special Issue
  • Volume 2014
  • - Article ID 205215
  • - Research Article

Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA

Clémentine Sarkozy | Nicolas Mounier | ... | Bertrand Coiffier
  • Lymphoma -
  • Special Issue
  • Volume 2013
  • - Article ID 583826
  • - Research Article

Primary Non-Hodgkin’s Lymphoma of Stomach: To Report 54 Patients and Analysis of Major Reported Series

Mansour Ansari | Hamid Nasrolahi | ... | Ahmad Mosalaei
  • Lymphoma -
  • Special Issue
  • Volume 2013
  • - Article ID 952698
  • - Review Article

Therapy-Related Late Adverse Events in Hodgkin’s Lymphoma

Manuel Gotti | Valeria Fiaccadori | ... | Maurizio Bonfichi
  • Lymphoma -
  • Special Issue
  • Volume 2013
  • - Article ID 123297
  • - Research Article

Is There Any Relationship between Human Herpesvirus-8 and Multiple Myeloma?

Mohammad Hadi Sadeghian | Maryam Mohammadnia Avval | ... | Gohar Shaghayegh
  • Lymphoma -
  • Special Issue
  • Volume 2013
  • - Article ID 782903
  • - Research Article

Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Adam K. Ahrens | Nagendra K. Chaturvedi | ... | Shantaram S. Joshi
  • Lymphoma -
  • Special Issue
  • Volume 2013
  • - Article ID 147176
  • - Research Article

The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin’s Lymphoma: The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym)

Fay J. Hlubocky | Kimberly Webster | ... | David Cella
  • Lymphoma -
  • Special Issue
  • Volume 2013
  • - Article ID 290585
  • - Research Article

Clinical Features and Prognosis of CD20 Negative Aggressive B-Cell Non-Hodgkins Lymphoma

Sumit Gaur | Osvaldo Padilla | Zeina Nahleh
  • Lymphoma -
  • Special Issue
  • Volume 2012
  • - Article ID 341629
  • - Research Article

Analysis of NF-B Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study

Terzah M. Horton | Andrea M. Sheehan | ... | Hao Liu
  • Lymphoma -
  • Special Issue
  • Volume 2012
  • - Article ID 346084
  • - Review Article

Diagnostic Workup of Small B Cell Lymphomas: A Laboratory Perspective

Kathryn Rizzo | Mehdi Nassiri
  • Lymphoma -
  • Special Issue
  • Volume 2012
  • - Article ID 215868
  • - Clinical Study

Successful Treatment in Children with Hodgkin Lymphoma in Greece; A 20-Year Experience in a Single Institution

Apostolos Pourtsidis | Dimitrios Doganis | ... | Helen Kosmidis
  • Lymphoma -
  • Special Issue
  • Volume 2012
  • - Article ID 405327
  • - Research Article

Combination Phototherapy with a Histone Deacetylase Inhibitor and a Potent DNA-Binding Bibenzimidazole: Effects in Haematological Cell Lines

Annabelle L. Rodd | Katherine Ververis | Tom C. Karagiannis
  • Lymphoma -
  • Special Issue
  • Volume 2012
  • - Article ID 290685
  • - Review Article

Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase Inhibitors

Annabelle L. Rodd | Katherine Ververis | Tom C. Karagiannis

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.